Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;8(2):130-6.
doi: 10.1038/nnano.2012.248. Epub 2013 Jan 20.

Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses

Affiliations

Peptide nanofibrils boost retroviral gene transfer and provide a rapid means for concentrating viruses

Maral Yolamanova et al. Nat Nanotechnol. 2013 Feb.

Abstract

Inefficient gene transfer and low virion concentrations are common limitations of retroviral transduction. We and others have previously shown that peptides derived from human semen form amyloid fibrils that boost retroviral gene delivery by promoting virion attachment to the target cells. However, application of these natural fibril-forming peptides is limited by moderate efficiencies, the high costs of peptide synthesis, and variability in fibril size and formation kinetics. Here, we report the development of nanofibrils that self-assemble in aqueous solution from a 12-residue peptide, termed enhancing factor C (EF-C). These artificial nanofibrils enhance retroviral gene transfer substantially more efficiently than semen-derived fibrils or other transduction enhancers. Moreover, EF-C nanofibrils allow the concentration of retroviral vectors by conventional low-speed centrifugation, and are safe and effective, as assessed in an ex vivo gene transfer study. Our results show that EF-C fibrils comprise a highly versatile, convenient and broadly applicable nanomaterial that holds the potential to significantly facilitate retroviral gene transfer in basic research and clinical applications.

PubMed Disclaimer

References

    1. PLoS One. 2009 Jul 30;4(7):e6461 - PubMed
    1. Biol Chem. 2011 Oct;392(10):887-95 - PubMed
    1. J Virol. 1998 Jun;72(6):4882-92 - PubMed
    1. Cell. 2007 Dec 14;131(6):1059-71 - PubMed
    1. Retrovirology. 2010 Jun 23;7:55 - PubMed

Publication types

MeSH terms

LinkOut - more resources